Further, IM was able to prevent in part the activation of ERK1/2 induced by CSF-1 confirming the involvement of ERK1/2 in the proliferative effect of CSF-1 in breast cancer cells (Figure 5B). The gene discussed is MAPK3; the disease is breast carcinoma.